466 related articles for article (PubMed ID: 24532095)
1. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
[TBL] [Abstract][Full Text] [Related]
2. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
Sheshala R; Khan N; Darwis Y
Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
[TBL] [Abstract][Full Text] [Related]
3. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
Cantor SL; Khan MA; Gupta A
Drug Dev Ind Pharm; 2015; 41(7):1156-64. PubMed ID: 25000481
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets.
Yan YD; Woo JS; Kang JH; Yong CS; Choi HG
Biol Pharm Bull; 2010; 33(8):1364-70. PubMed ID: 20686233
[TBL] [Abstract][Full Text] [Related]
5. Freeze drying of orally disintegrating tablets containing taste masked naproxen sodium granules in blisters.
Stange U; Führling C; Gieseler H
Pharm Dev Technol; 2015 Dec; 20(8):1018-1024. PubMed ID: 25220888
[TBL] [Abstract][Full Text] [Related]
6. Preparation and Optimization of Fast-Disintegrating Tablet Containing Naratriptan Hydrochloride Using D-Optimal Mixture Design.
Omar SM; AbdAlla FI; Abdelgawad NM
AAPS PharmSciTech; 2018 Aug; 19(6):2472-2487. PubMed ID: 29869307
[TBL] [Abstract][Full Text] [Related]
7. Influence of non-water-soluble placebo pellets of different sizes on the characteristics of orally disintegrating tablets manufactured by freeze-drying.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2013 Jun; 102(6):1786-1799. PubMed ID: 23568590
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Vural İ; Ünlü N
Pharm Dev Technol; 2018 Jun; 23(5):488-495. PubMed ID: 28368673
[TBL] [Abstract][Full Text] [Related]
9. Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2015 Apr; 41(4):583-93. PubMed ID: 24495273
[TBL] [Abstract][Full Text] [Related]
10. Taste masking of naproxen sodium granules by fluid-bed coating.
Stange U; Führling C; Gieseler H
Pharm Dev Technol; 2014 Mar; 19(2):137-47. PubMed ID: 23324020
[TBL] [Abstract][Full Text] [Related]
11. Formulation and evaluation of bitter taste-masked orally disintegrating tablets of high memantine hydrochloride loaded granules coated with polymer via layering technique.
Kadota K; Terada H; Fujimoto A; Nogami S; Uchiyama H; Tozuka Y
Int J Pharm; 2021 Jul; 604():120725. PubMed ID: 34029663
[TBL] [Abstract][Full Text] [Related]
12. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
[TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of unpleasant taste-masked pioglitazone orally disintegrating tablets.
Nakano Y; Maeda A; Uchida S; Namiki N
Int J Pharm; 2013 Mar; 446(1-2):160-5. PubMed ID: 23419665
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
[TBL] [Abstract][Full Text] [Related]
15. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations.
Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W
Drug Dev Ind Pharm; 2015 Apr; 41(4):540-51. PubMed ID: 24495274
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
Drašković M; Medarević D; Aleksić I; Parojčić J
Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
[TBL] [Abstract][Full Text] [Related]
17. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
[TBL] [Abstract][Full Text] [Related]
20. Formulation studies for mirtazapine orally disintegrating tablets.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
